China launches fresh attack on UK in retaliation for poisoned ties with Beijing – Daily Express

Chinas ambassador to London, Liu Xiaoming, warned the UK it would pay the price if it shunned Beijing.Mr Xiaoming was remarking on the heated disputes over the Hong Kong tech giant Huawei and the alleged human rights abuses in Xinjiang.

He said Britain was at a critical historical juncture in how it wanted to treat China.

The Chinese ambassador also appeared to reference Donald Trumps administration by cautioning the UK against allowing Cold War warriors to further damage relations.

Mr Xiaoming was speaking at a live news conference broadcast on Twitter when he made his remarks.

He rejected any claims made about the abuses towards Uighur Muslims.

During the conference, he also criticised the Governments decision to exclude Huawei from the UKs 5G network.

He also urged the UK not to interfere with Chinas affairs in Hong Kong.

He said: These actions have seriously poisoned the atmosphere of the China-UK relationship.

China respects UK sovereignty and has never interfered in the UKs internal affairs.

READ MORE:China's 'unusual' threat to UK indicates big dilemma facing Beijing

It is important the UK will do the same - namely, respect Chinas sovereignty and stop interfering in Hong Kongs affairs, which are Chinas internal affairs, so as to avoid further damage to the China-UK relationship.

Mr Xiaoming said his comments were intended to threaten nobody.

He added: We just let you know the consequences.

People regard some of my remarks as threatening words.

DON'T MISSSouth China Sea: China orders Trump to 'stop interfering' [UPDATE]China threat: Fearsome new Indian fighter jets warn China of conflict [INSIGHT]WW3 warning: Russia and China investing in submarines to target US[ANALYSIS]

I think they quote my remarks out of context.

But, if you do not want to be our partners and our friends, you want to treat China as a hostile country, you will pay the price.

That means you will lose the benefits of treating China as opportunities, as friends.

And you will bear the consequences of treating China as a hostile country.

Mr Trumps administration has encouraged allies to distance themselves from Beijing.

Britains Foreign Secretary, Dominic Raab, has said the UK-China relations would not return to normal amid the disputes between the two countries.

The Chinese ambassador urged the UK not to follow in the footsteps of other countries.

Mr Xiaoming said: Its our hope that the UK would resist the pressure and coercion from a certain country and provide an open, fair, transparent and non-discriminatory environment for Chinese investment so as to bring back the confidence of Chinese business in the UK.

He added: Its hard to imagine a global Britain that bypasses or excludes China.

Decoupling from China means decoupling from opportunities, decoupling from growth and decoupling from the future.

Read this article:

China launches fresh attack on UK in retaliation for poisoned ties with Beijing - Daily Express

Posted in Ww3

The NBA, China and racial justice: How to untangle the leagues messy relationship with human rights – Yahoo Sport Australia

Here are two statements:

The NBA, by professional sports league standards, has a decently strong record on human rights. It allows players to speak their minds. It believes that Black lives matter. It uses its power to fight injustice in the United States.

The NBA, an adored global corporation, has also gone to great lengths to build and maintain a multibillion-dollar relationship with a human rights-abusing government halfway around the world.

They are two factual statements that at this time last year coexisted peacefully. Yet recently, theyve become entangled, pitted against each other, by U.S. senators and laypeople alike. On Thursday, when the NBA season resumes, activism will be inescapable; players will protest police brutality and racial injustice in America; BLACK LIVES MATTER will scream at viewers off courts. And perhaps the most common criticism of the NBAs initiatives will be a prickly diversion.

But what about China?!?

Its a fascinating retort, because its grounded in the most glaring demerit on the NBAs recent record. An ESPN investigation published Wednesday raised more red flags. For years, the league ignored authoritarian crackdowns and ethnic persecution as it built and monetized a rabid fan base in China. It ran an abusive basketball academy in a police state where Muslims are interned in concentration camps. When Houston Rockets general manager Daryl Morey tweeted in support of Hong Kong last October, and the Chinese government attacking democratic freedoms in Hong Kong bristled, the NBA moved swiftly to salvage its relationship with that government. The leagues most prominent figures, from LeBron James to Steve Kerr, didnt rush to condemn injustice, as they had so often in the past and have so often since. Instead, they either criticized Morey, or remained conspicuously silent. Officials, in some cases, stepped in to silence them.

The silence was embarrassing. It enables and legitimizes oppression. Sure, the NBA actually stood up to China with more strength than most corporations do. But the widespread disapproval it received was deserved. Where things got messy, and problematic, was when that disapproval became bottomless ammo for whataboutism. When China became the catch-all counter. When injustice became the response to calls for justice.

We can, and should, criticize the league and its most prominent characters for refusing to outright condemn oppression in China. We also can, and should, support the league and its most prominent characters as they try to combat oppression closer to home. Our criticism and support arent contradictory. In fact, they necessarily go hand in hand.

When the NBA returns to action Thursday, some players will wear racial justice messages on their uniforms, and courts will declare, "BLACK LIVES MATTER." (AP)

Injustice clouds every second of every day in every country. To use the neglect of some injustice to detract from the fight against other injustice is to uphold all of it. Change is local. Successful fights for it are often hyper-focused. Black Americans, some of whom comprise a majority of the NBA, are trying to lead one. To support their fight, to affirm that Black lives matter, to do your part to dismantle systemic racism, is not an affront to Muslims detained in China, or families brutalized in Syria, or women denied rights in Iran, or LGBTQ+ people denied humanity everywhere.

To support NBA players advocacy is to fight for human rights, period. They are attacking one web of injustice among many. To refuse to support their fight because they havent attacked another web of injustice is hypocritical. It is unfair, and counterproductive, to criticize progressive action on the basis of inaction elsewhere. If we do, progress is unattainable.

Now, it is fair to separately criticize the inaction especially when that inaction could be described as suppression of action in the name of profit. We should acknowledge, and scrutinize, why the NBA cuddles up and cowers to China. It lost hundreds of millions of dollars in the wake of Moreys tweet. If it were to push harder for democratic freedoms in Hong Kong, it would lose more. Those losses hit the league, and spread to teams, and filtered down to players and employees. Which is why they all say nothing. The NBA believes in human rights, and recognizes how powerfully it can advocate for them. It pulled the 2017 All-Star Game out of North Carolina to pressure the state to protect them. But somewhere between Carolina and China, it drew its line. A line between social responsibility and money.

Story continues

We all have one. Every corporation, every institution, every individual. Even the most well-meaning people like and need money. Some arent willing to sacrifice any of it to make the world a better place. Some are. Everybody, though, is faced with the question of how much?

You can argue, and many would, that the NBA should sacrifice more. That the line should stretch well beyond China and those hundreds of millions of dollars. That no American company not the NFL, not Nike, not Apple should deal with China. (They all do.) But you probably cant argue the line shouldnt exist. If you believe the NBA should fight any injustice at any cost, then you, too, should quit your job and go fight injustice; then every company, regardless of industry, should cease production of their goods or services and pour all resources into the battle. Of course, thats unrealistic. The world will never be, cannot be, 100 percent selfless.

The NBA, like so many others, does the right thing until the right thing is too costly. We can, and should, criticize the billionaires who own it for not spending more in the name of human rights because thats essentially what this is. We can, and should, criticize the league for its response to Morey. We can, and should, criticize LeBron.

Because injustice is injustice, whether we, personally, feel it or not.

And that, precisely, is also why we must support the NBA players crusading against it.

You can, and should, call them out for not condemning all injustice. But if you do so to undermine their condemnations of some injustice, then youre not condemning all injustice yourself.

We care about Chinas oppression because were empathetic, and believe injustice is wrong. For the exact same reason, we will listen to NBA players on Thursday and beyond; we have heard them speak about the violence and prejudice they and their communities experience; we will hear them say, as a collective, that Black lives matter, and that systemic racism must end; and we will say, Yes. Absolutely.

More from Yahoo Sports:

Visit link:

The NBA, China and racial justice: How to untangle the leagues messy relationship with human rights - Yahoo Sport Australia

IBM, University of Tokyo Launch the Quantum Innovation Initiative Consortium – HPCwire

TOKYO,July 30, 2020 IBM and theUniversity of Tokyounveiled a landmark collaboration with the launch of the Quantum Innovation Initiative Consortium (QIIC). Expanding from theDecember 2019JapanIBM Quantum Partnership initiative, QIIC, aims to accelerate the collaboration between industry, academia, and government to advanceJapansleadership in quantum science, business, and education.

QIICs main goal is to strategically accelerate quantum computing R&D activities inJapanby bringing together academic talent from across the countrys universities and prominent research associations and large-scale industry. The consortium plans to further develop technology for quantum computing inJapanand build an ecosystem to improve student skills and expertise, opening doors to future scientific discoveries and practical quantum applications.

Headquartered at theUniversity of Tokyo, member organizations of QIIC will collaborate to engage students, faculty, and industry researchers with seminars, workshops, and events to foster new quantum business opportunities inJapan. Organizations in agreement to join the consortiumincludeKeio University, Toshiba, Hitachi, Mizuho,MUFG, JSR, DIC, Toyota, Mitsubishi Chemicals and IBM Japan.

These organizations in consortium will also be part of the IBM Q Network the worlds first community of Fortune 500 companies, startups, academic institutions and research labs to advance quantum computing and the development of practical applications for it. As part of the network, they will have access to IBMs expertise and resources, and cloud development environment, as well as cloud-based access to the IBM Quantum Computation Center, which includes IBMs most-advanced quantum computers.

In addition to cloud-based access to the IBMs fleet of quantum systems, the QIIC will also have access to an IBM Q System One, a dedicated system planned for installation inJapanin 2021. The first of its kind in the region, and only the second such installation outside of the US, this system along with a separate testbed system to be part of a system technology development lab will support the consortiums goals of next-generation quantum hardware research and development, including cryogenic components, room temperature electronics, and micro-signal generators.

According to ProfessorMakoto Gonokami, President of theUniversity of Tokyo:

Society 5.0is the concept of a better future with inclusive, sustainable and a knowledge-intensive society where information and services create value underpinned by digital innovation. The key to realizing this society is to utilize real data in real-time. In order to achieve this, it is necessary to protect and nurture the global environment, an entity of physical space and cyberspace as one, by taking it as a global commons (a concept that encompasses global resources and the ecosystems) which is sustainable and reliable, while the fusion of physical space and cyberspace progresses.

Quantum technology and quantum computers are indispensable technologies to make that happen. I believe thatJapanwill play an important role in implementing quantum computing technology to society ahead of rest of the world, and that industry-academia-government collaboration is necessary for this. The QIIC will accelerate quantum technology research and its implementation to the Society 5.0 while firmlysharing each others wisdom and promoting the close sharing of information.

Today, I am extremely excited and proud to launch this new consortium that will help foster economic growth and quantum technology leadership in Japan.The QIIC will greatly advanceJapansentire quantum computing ecosystem, bringing experts from industry, government and academia together to collaborate on researchand development, saidDario Gil, Director of IBM Research. Quantum computing has the potential totackle some of the worlds greatest challengesin the future.We expect that it will helpusaccelerate scientific discovery so that we candevelop vaccinesmore quickly and accurately,create new materials toaddressclimate changeor design better energy storage technologies. The potential is massive,andwe will only reach this future if we work together uniting the best minds from the public and private sectors. Universities, businesses and governments have to collaborate so that we can unleash the full potential of quantum computing.

QIICs members are forging a path forJapansdiscovery of practical quantum applications for the benefit of society. The cooperation between industry, academia, and government aims to create a new community for quantum computation research and use cases.

About IBM Quantum

IBM Quantum is an industry-first initiative to build quantum systems for business and science applications. For more information about IBMs quantum computing efforts, please visitwww.ibm.com/ibmq.

For more information about the IBM Q Network, as well as a full list of all partners, members, and hubs, visithttps://www.research.ibm.com/ibm-q/network/

About TheUniversity of Tokyo

TheUniversity of Tokyowas established in 1877 as the first national university inJapan. As a leading research university, theUniversity of Tokyois conducting academic research in almost all fields at both undergraduate and graduate schools. The University aims to provide its students with a rich and varied academic environment that ensures opportunities for acquiring both academic and professional knowledge and skills.

Source: IBM

See the article here:

IBM, University of Tokyo Launch the Quantum Innovation Initiative Consortium - HPCwire

Artificial Intelligence Loses Some Of Its Edginess, But Is Poised To Take Off – Forbes

AI advances

More than a decade ago, Nicholas Carr,in his workDoes IT Matter, suggested that the widespread availability and low prices of technology made it more of a utility like electricity or water, versus a competitive differentiator. This may be happening with artificial intelligence to some degree.

It appears that AIs early adopter phase is ending; the market is now moving into the early majority chapter of this maturing set of technologies, write Beena Ammanath, David Jarvis and Susanne Hupfer, all with Deloitte, in their most recent analysis of the enterprise AI space. Early-mover advantage may fade soon. As adoption becomes ubiquitous, AI-powered organizations may have to work harder to maintain an edge over their industry peers.

Seventy-four prevent of 2,727 executives responding to a Deloitte survey agree that AI will be integrated into all of their enterprise applications within three years. Although adopters are still bullish on AI, their advantage may wane as barriers to adoption fall and usage grows, Ammanath and her co-authors state. Organizations are finding it easier and easier to employ AI technologies. Data science and machine learning platforms have proliferated; AI-optimized hardware is providing greater compute power. It is now easier to train algorithms through self-service data preparation tools, synthetic data, small data, and pretrained models.

It is increasingly clear that we are on the path toward an era of pervasive AI, they add. The challenge now is leveraging AI in innovative ways to maintain its advantages, the study finds. For example, much of the work with AI is still confined to managing IT systems. In addition, there still isnt enough AI talent to go around.

At least 26% of the companies surveyed can be considered seasoned AI adopters, meaning they have undertaken a large number of AI production deployments and have developed a high level of AI expertise across the board. These AI leaders are still seeing competitive advantage 45% of this group said that AI technologies have enabled them to establish a significant lead over their competitors, versus 26% of the entire sample.

Still, this means a majority of even the most advanced AI companies, 55%, still arent seeing competitive advantage. Part of this may be due to the fact that AI is still confined to IT departments and functions, including cybersecurity Forty-seven percent of respondents indicated that IT was one of the top two functions for which AI was primarily used, the survey shows.

This could mean that companies are using AI for IT-related applications such as analyzing IT infrastructure for anomalies, automating repetitive maintenance tasks, or guiding the work of technical support teams, Ammanath and her co-authors note. Tellingly, business functions such as marketing, human resources, legal, and procurement ranked at the bottom of the list of AI-driven functions.

An area that needs work is finding or preparing individuals to work with AI systems. Fewer than half of executives (45%) say they have a high level of skill around integrating AI technology into their existing IT environments, the survey shows. This could include data science and machine learning platforms, enterprise applications powered by AI, tools for developing conversation interfaces, and low-code or no-code tools. Across all these different technology areas, 93% are using cloud-based AI capabilities, while 78% employ open-source AI capabilities.

Ammanath and her team offer some suggestions for keeping the edge with AI:

Pursue creative approaches. Take inspiration from inventive use cases to develop solutions that are both useful and novel.

Push boundaries. Expand your view of what may be possible to accomplish with AI technologies. Try to pursue a more diverse portfolio of projects that could potentially enhance multiple business functions across the enterprise.

Create the new. Look to develop new AI-powered products and services that take advantage of the technologies ability to learn and solve problems that humans cant.

Expand the circle. Move AI beyond the IT department by involving more of the business in AI efforts. Look for new vendors, partnerships, data sources, tools, and techniques to advance your efforts.

Leverage a diverse team. Include both technical and business experts in selecting AI technologies and suppliers. Having a broad perspective from developers, integrators, end users, and business owners can help ensure organizational alignment and a focus on business outcomes. Along with any vendor support consider using working groups, dedicated leaders, or communities of practice.

Actively address risks. Developing a set of principles and processes to actively manage the range of AI risks can help build trust within your business and with customers and partners.

Challenge vendors. While it is important to build trust and transparency with providers of your AI-powered systems, it can be equally essential to ensure that what they provide is aligned with your organizations ethical principles.

More:

Artificial Intelligence Loses Some Of Its Edginess, But Is Poised To Take Off - Forbes

How artificial intelligence is transforming the world in the current pandemic situation? – Geospatial World

Artificial intelligence (AI) is a wide-ranging tool that allows individuals to reconsider how we can all mix data, examine information, and use the subsequent understandings to conclude. Already it is altering each way of our life. AIs application in various sectors has been applied drastically. They address problems in the expansions and provide approvals for receiving the most from artificial intelligence while still caring for significant human values.

Artificial intelligence (AI) is changing our way of life, meaning to impersonate human insight by a PC/machine in settling different issues. At first, AI was intended to defeat more manageable issues like dominating a chess match, language recognition, and picture recovery. With the innovative headways, AI is getting progressively sophisticated at doing what people do, yet more effectively, quickly, and at a lower cost in tackling complex issues. Artificial intelligence is paying attention in combating the current pandemic. Projects directly is associated to pharmacology, hospital and medical care, or stretch inspection to decrease infection have seen a critical supporter in data science to make development and bring positive results.

The pandemic taken place due to COVID-19 is the initial worldwide public health disaster in the 21st century. At present, numerous AI-driven projects depended on data science big data or machine learning is being used through many wide varieties of areas to envisage, clarify and handle the dissimilar situations that take place due to health disaster. AI over here is playing an essential role in supporting and aiding to make important decisions.

AI has been used and delivered in getting results in three fields in the situation of the epidemic that is in the investigation of virus study and the growth of medicines and injections. The other one is in the administration of resources and services at healthcare places. While the last is in examining data to sustenance public policy choices meant at handling the disaster, like the quarantine procedures.

Below are a few methods where AI technology is used to help restrain the disturbing effect of the virus.

Currently, the data needed for measuring a persons scientific danger from constricting an assumed virus are not effortlessly retrieved. Administrations surely can increase nationwide fitness information congregation by making or passing many complete electric medical records. Nonetheless, the worth of such might be less as it will be time consuming to arise among the past data in medicinal archives and the impact on a victim. AI gives the best method that can make as well as share a prediction model from an original outbreak. A dataset with several victims is huge to allow a few levels of the modified forecast.

The earlier interferences are taken to stalk the current of an epidemic, the additional successful they are at decelerating and discontinuing the spread. This is why the initial examination of a crisis in the expansion is very much needed. Many AI solutions companies are energetically using AI to forecast outbursts of infectious viruses.

Even the geolocation and facial recognition technology is being used to track people who might contact COVID -19 patients. With AI tools, one could even use to trail amenability with quarantine and self-isolation orders. AI potential has always been very clear during the crisis. At the time of the pandemic, when time plays an important part, AI can help as an important tool in assisting the researchers excavate understandings from large bands of data.

Also Read: How Smart Cities are Fighting the COVID-19 Pandemic

Researchers are making use of AI to assist them to mine data for perceptions. This similar method is sued even previously to recognize a possible use of circumstance for magnesium in the handling of a recurrent throbbing headache. Thus, artificial intelligence procedures permit us to identify and modify medical care and follow-up strategies for the best outcomes.

Although AI has not totally progressed to overcome an epidemic, nonetheless, the part of AI is markedly huge at the time of COVID19 as compared to the one that was initially. It is correctly applied as a tool perfecting humanoid intelligence.

To summarize, the entire nation is on the point of transforming numerous sectors during the pandemic with the help of data analytics and artificial intelligence. There already are important dispositions in the backing, nationwide security, fitness care, transport, and so on that have changed decision-making, commercial prototypes, danger extenuation, and organization performance. These expansions are making sizeable social and economic advantages.

Also Read: COVID-19: When a crisis becomes a catalyst for change

Follow this link:

How artificial intelligence is transforming the world in the current pandemic situation? - Geospatial World

The NBA will use artificial intelligence and a tap-to-cheer app feature to help fans stuck at home get in the game – CNN

But knowing what a difference their support can make (home court advantage, anyone?) the NBA is proposing a few solutions: a tap-to-cheer app and video technology that will teleport their faces court-side from the comfort of their homes.

"It's obviously very different for the players and it's different for the fans watching at home. I mean, in this sport -- like a lot of others -- there's that home court advantage, that six-man. It's the roar of the crowd, the boos of the crowd," said NBA commissioner Adam Silver Wednesday on CNN with Wolf Blitzer. "We are trying to replicate that to a certain extent without piping in obvious crowd noise."

It's still unclear what kind of difference this technology will make in the overall atmosphere of a sporting match, though.

Not every attempt has been successful, though.

In South Korea, FC Seoul was fined 100 million Korean won (around $81,000) after being accused of placing sex dolls in its stands to add to the atmosphere during a closed match.

CNN's Jack Guy contributed to this report.

Go here to see the original:

The NBA will use artificial intelligence and a tap-to-cheer app feature to help fans stuck at home get in the game - CNN

Different Scopes Of Artificial Intelligence To Dive In With! – Inventiva

What is artificial intelligence and why is it so famous?

Artificial intelligence is the talk of the town. It is the simulation of human intelligence with the usage of machines and especially the management of the computer system. AI can be categorized in a lot of streams. This means that their primary basis of categorization is dependent on the weakness and how strong they can be. We all know that the application of Artificial intelligence is increasing in this modern world, and each and every technology is managing their resources in the right way. Take, for example, apples voice control uses their Artificial intelligence known as Siri to communicate and get your work done in the best of form.

How is it changing the current scenario?

Here is the list of features and advantages of using Artificial intelligence.

Units of Artificial Intelligence

These are the following units of AI which work for the current period.

All these units of artificial intelligence have different features of their own. These units are fundamental in your life, and they help to paint the whole world. AI is the new simulation of the human, which allows you to process data and include the techniques of learning. We need AI for the work we do. It becomes an automated routine for us to use their units for our daily work. Like take, for example, the usage of robotics is increasing, and it is said to cross a massive platform in a few years. Even though it is a sub-field, it holds as much crucial as the central concept. And if you are interested then you can choose one field and excel in the same.

Does the work for you

Artificial intelligence is changing the current scenario in the way you have never seen before. The smallest of activities are being conducted by them. They dont need to take breaks like us. If you work regularly, then your body might give up on you, but Artificial intelligence wont ever do the same. They are programmed to work for a very long period. They dont need lunch breaks, and neither can they ever get tired. You need to recharge their cells so that they dont shut off.

Like Loading...

Related

Go here to see the original:

Different Scopes Of Artificial Intelligence To Dive In With! - Inventiva

Gatling Exploration to use artificial intelligence to identify possible gold targets at the Larder project in Ontario – Proactive Investors USA &…

AI experts with Windfall Geotek will use their advanced Computer Aided Resource Detection System to mark targets using pattern recognition and machine learning

Inc ()(OTCQX:GATGF) announced Thursday it will employ artificial intelligence (AI) to identify possible gold targets at the Larder gold project in Ontario.

The company said AI experts with Windfall Geotek will use their advanced Computer Aided Resource Detection System (CARDS) to marktargets which will be evaluated and explored using traditional exploration techniques in upcoming programs.

Gatling's Larder Gold project occupies 3,370 hectares along the Cadillac Larder Lake Break, a prolific structural gold trend. The property hosts three high-grade deposits along the main break, as well as two additional, underexplored gold trends, recently discovered 6 kilometers north.

The company said AI uses pattern recognition and machine learning to make predictions based on compiled datasets. The Larder project benefits from a vast database of recent and historical data, including 2,000 drill holes, 90,000 assays, 1,000 surface rock samples, 500 soil samples, as well as geophysics, Lidar and bedrock geology.

The area to be analyzed has numerous deposits including, but not limited to, Agnico Eagle's Upper Beaver, Kerr Addison, Mistango River Resources' Omega Mine and Gatling's 3 high-grade gold deposits: Fernland, Cheminis and Bear,Gatling said in a statement.

These known gold deposits will be instrumental in guiding the AI, with the goal of highlighting areas on Larder that may be geologically similar to other deposits in the district.

Contact the author: [emailprotected]

Follow him on Twitter @PatrickMGraham

View post:

Gatling Exploration to use artificial intelligence to identify possible gold targets at the Larder project in Ontario - Proactive Investors USA &...

Church body recommends restrictions on Artificial Intelligence – The Tablet

Intelligent robots are displaying on the ground floor of Shanghai Expo Centre, Shanghai, China, 9 July 2020. ChinaImages/SIPA USA/PA Images

A commission representing the European Union's Catholic bishops has called on EU institutions to follow a "human-centric approach" on Artificial Intelligence, ensuring new information technologies "promote the common good and serve the lives of all human beings".

"AI is a strategic technology that offers many benefits for citizens and the economy - it will change our lives by improving healthcare, increasing the efficiency of farming, contributing to climate change mitigation andadaptation and improving the efficiency of production systems", the COMECE report said. COMECE, aBrussels-based commission, represents the EU's Catholic bishops inside and outwith Europe.

"At the same time, AI entails a number of potential risks, such as gender-based or other kinds of discrimination, opaque decision-making or intrusion into our private lives...AI should work for people and be a force for good in society".

The report, published as part of an EU consultation, said the Catholic Church welcomed attempts to establish a "solid European approach" to AI, which would be "deeply grounded on human dignity and protection of privacy", and cover child safety, data protection, cyber-security and money-laundering.

It added that, while that data and algorithms were "main drivers of Artificial Intelligence", human beings remained responsible for "determining and overviewing" its goals, which should be coordinated at EU level rather than left to national governments.

"AI has to serve the lives of all human beings - human life has not only a personal dimension but also a community dimension", the COMECE report said.

"The Christian perspective sees the human person as qualitatively different from other beings, with a transcendental dignity, intelligent and free, and therefore capable of moral acts. AI systems are not free in the sense the human person is and, in this sense, their actions cannot be judged according to the same moral criteria".

In February, the Vatican's Pontifical Academy for Life published a "Rome Call for AI Ethics" after an international workshop chaired by its president, Archbishop Vincenzo Paglia.

The Pontifical Academy invited the leaders of Microsoft and IBM, two of the world's leading developers of AI, to sign a charter calling for an ethical framework for the field of artificial intelligence.

Read more here:

Church body recommends restrictions on Artificial Intelligence - The Tablet

Elon Musk Thinks that Artificial Intelligence Will Be ‘Vastly Smarter’ Than Humans in 5 Years – News18

File photo of Tesla CEO Elon Musk. (Image credits: Reuters)

Tesla and SpaceX CEO Elon Musk has claimed that Artificial Intelligence will be 'vastly smarter' than any human and would overtake us by 2025.

"We are headed toward a situation where AI is vastly smarter than humans. I think that time frame is less than five years from now. But that doesn't mean that everything goes to hell in five years. It just means that things get unstable or weird," Musk said in an interview with New York Times over the weekend.

This is not the first time that Musk has shown concern related to AI. Back in 2016, Musk said that humans risk being treated like house pets by AI unless technology is developed that can connect brains to computers.

He even described AI as an 'existential threat' to humanity.

"I think we should be very careful about artificial intelligence. If I were to guess like what our biggest existential threat is, it's probably that,'' he said.

However, Musk helped found the artificial intelligence research lab OpenAI in 2015 with the goal of developing artificial general intelligence (AGI) that can learn and master several disciplines.

Recently, OpenAI released its first commercial product, a programme to make use of a text-generation tool that it once called too dangerous.

It has the potential to spare people from writing long texts. Once an application is developed on the basis of the programme, all they need to give is a prompt.

OpenAI earlier desisted from revealing more about the software fearing bad actors might misuse it for producing misleading articles, impersonate others or even automate phishing content.

See the rest here:

Elon Musk Thinks that Artificial Intelligence Will Be 'Vastly Smarter' Than Humans in 5 Years - News18

How the Coronavirus Pandemic Is Breaking Artificial Intelligence and How to Fix It – Gizmodo

As covid-19 disrupted the world in March, online retail giant Amazon struggled to respond to the sudden shift caused by the pandemic. Household items like bottled water and toilet paper, which never ran out of stock, suddenly became in short supply. One- and two-day deliveries were delayed for several days. Though Amazon CEO Jeff Bezos would go on to make $24 billion during the pandemic, initially, the company struggled with adjusting its logistics, transportation, supply chain, purchasing, and third-party seller processes to prioritize stocking and delivering higher-priority items.

Under normal circumstances, Amazons complicated logistics are mostly handled by artificial intelligence algorithms. Honed on billions of sales and deliveries, these systems accurately predict how much of each item will be sold, when to replenish stock at fulfillment centers, and how to bundle deliveries to minimize travel distances. But as the coronavirus pandemic crisis has changed our daily habits and life patterns, those predictions are no longer valid.

In the CPG [consumer packaged goods] industry, the consumer buying patterns during this pandemic has shifted immensely, Rajeev Sharma, SVP and global head of enterprise AI solutions & cognitive engineering at AI consultancy firm Pactera Edge, told Gizmodo. There is a tendency of panic buying of items in larger quantities and of different sizes and quantities. The [AI] models may have never seen such spikes in the past and hence would give less accurate outputs.

Artificial intelligence algorithms are behind many changes to our daily lives in the past decades. They keep spam out of our inboxes and violent content off social media, with mixed results. They fight fraud and money laundering in banks. They help investors make trade decisions and, terrifyingly, assist recruiters in reviewing job applications. And they do all of this millions of times per day, with high efficiencymost of the time. But they are prone to becoming unreliable when rare events like the covid-19 pandemic happen.

Among the many things the coronavirus outbreak has highlighted is how fragile our AI systems are. And as automation continues to become a bigger part of everything we do, we need new approaches to ensure our AI systems remain robust in face of black swan events that cause widespread disruptions.

Key to the commercial success of AI is advances in machine learning, a category of algorithms that develop their behavior by finding and exploiting patterns in very large sets of data. Machine learning and its more popular subset deep learning have been around for decades, but their use had previously been limited due to their intensive data and computational requirements. In the past decade, the abundance of data and advances in processor technology have enabled companies to use machine learning algorithms in new domains such as computer vision, speech recognition, and natural language processing.

When trained on huge data sets, machine learning algorithms often ferret out subtle correlations between data points that would have gone unnoticed to human analysts. These patterns enable them to make forecasts and predictions that are useful most of the time for their designated purpose, even if theyre not always logical. For instance, a machine-learning algorithm that predicts customer behavior might discover that people who eat out at restaurants more often are more likely to shop at a particular kind of grocery store, or maybe customers who shop online a lot are more likely to buy certain brands.

All of those correlations between different variables of the economy are ripe for use by machine learning models, which can leverage them to make better predictions. But those correlations can be ephemeral, and highly context-dependent, David Cox, IBM director at the MIT-IBM Watson AI Lab, told Gizmodo. What happens when the ground conditions change, as they just did globally when covid-19 hit? Customer behavior has radically changed, and many of those old correlations no longer hold. How often you eat out no longer predicts where youll buy groceries, because dramatically fewer people eat out.

As consumers change their habits, the intrinsic correlations between the myriad variables that define the behavior of a supply chain fall apart, and those old prediction models lose their relevance. This can result in depleted warehouses and delayed deliveries on a large scale, as Amazon and other companies have experienced. If your predictions are based on these correlations, without an understanding of the underlying causes and effects that drive those correlations, your predictions will be wrong, said Cox.

The same impact is visible in other areas, such as banking, where machine learning algorithms are tuned to detect and flag sudden changes to the spending habits of customers as possible signs of compromised accounts. According to Teradata, a provider of analytics and machine learning services, one of the companies using its platform to score high-risk transactions saw a fifteen-fold increase in mobile payments as consumers started spending more online and less in physical stores. (Teradata did not disclose the name of the company as a matter of policy.) Fraud-detection algorithms search for anomalies in customer behavior, and such sudden shifts can cause them to flag legitimate transactions as fraudulent. According to the firm, it was able to maintain the accuracy of its banking algorithms and adapt them to the sudden shifts caused by the lockdown.

But the disruption was more fundamental in other areas such as computer vision systems, the algorithms used to detect objects and people in images.

Weve seen several changes in underlying data due to covid-19, which has had an impact on performances of individual AI models as well as end-to-end AI pipelines, said Atif Kureishy, VP of global emerging practices, artificial intelligence and deep learning for Teradata. As people start wearing masks due to the covid-19, we have seen performance decay as facial coverings introduce missed detections in our models.

Teradatas Retail Vision technology uses deep learning models trained on thousands of images to detect and localize people in the video streams of in-store cameras. With powerful and potentially ominous capabilities, the AI also analyzes the video for information such as peoples activities and emotions, and combines it with other data to provide new insights to retailers. The systems performance is closely tied to being able to locate faces in videos, but with most people wearing masks, the AIs performance has seen a dramatic performance drop.

In general, machine and deep learning give us very accurate-yet-shallow models that are very sensitive to changes, whether it is different environmental conditions or panic-driven purchasing behavior by banking customers, Kureishy said.

We humans can extract the underlying rules from the data we observe in the wild. We think in terms of causes and effects, and we apply our mental model of how the world works to understand and adapt to situations we havent seen before.

If you see a car drive off a bridge into the water, you dont need to have seen an accident like that before to predict how it will behave, Cox said. You know something (at least intuitively) about why things float, and you know things about what the car is made of and how it is put together, and you can reason that the car will probably float for a bit, but will eventually take on water and sink.

Machine learning algorithms, on the other hand, can fill the space between the things theyve already seen, but cant discover the underlying rules and causal models that govern their environment. They work fine as long as the new data is not too different from the old one, but as soon as their environment undergoes a radical change, they start to break.

Our machine learning and deep learning models tend to be great at interpolationworking with data that is similar to, but not quite the same as data weve seen beforebut they are often terrible at extrapolationmaking predictions from situations that are outside of their experience, Cox says.

The lack of causal models is an endemic problem in the machine learning community and causes errors regularly. This is what causes Teslas in self-driving mode to crash into concrete barriers and Amazons now-abandoned AI-powered hiring tool to penalize a job applicant for putting womens chess club captain in her resume.

A stark and painful example of AIs failure to understand context happened in March 2019, when a terrorist live-streamed the massacre of 51 people in New Zealand on Facebook. The social networks AI algorithm that moderates violent content failed to detect the gruesome video because it was shot in first-person perspective, and the algorithms had not been trained on similar content. It was taken down manually, and the company struggled to keep it off the platform as users reposted copies of it.

Major events like the global pandemic can have a much more detrimental effect because they trigger these weaknesses in a lot of automated systems, causing all sorts of failures at the same time.

It is imperative to understand that the AI/ML models trained on consumer behavior data are bound to suffer in terms of their accuracy of prediction and potency of recommendations under a black swan event like the pandemic, said Pacteras Sharma. This is because the AI/ML models may have never seen that kind of shifts in the features that are used to train them. Every AI platform engineer is fully aware of this.

This doesnt mean that the AI models are wrong or erroneous, Sharma pointed out, but implied that they need to be continuously trained on new data and scenarios. We also need to understand and address the limits of the AI systems we deploy in businesses and organizations.

Sharma described, for example, an AI that classifies credit applications as Good Credit or Bad Credit and passes on the rating to another automated system that approves or rejects applications. If owing to some situations (like this pandemic), there is a surge in the number of applicants with poor credentials, Sharma said, the models may have a challenge in their ability to rate with high accuracy.

As the worlds corporations increasingly turn to automated, AI-powered solutions for deciding the fate of their human clients, even when working as designed, these systems can have devastating implications for those applying for credit. In this case, however, the automated system would need to be explicitly adjusted to deal with the new rules, or the final decisions can be deferred to a human expert to prevent the organization from accruing high risk clients on its books.

Under the present circumstances of the pandemic, where model accuracy or recommendations no longer hold true, the downstream automated processes may need to be put through a speed breaker like a human-in-the-loop for added due diligence, he said.

IBMs Cox believes if we manage to integrate our own understanding of the world into AI systems, they will be able to handle black swan events like the covid-19 outbreak.

We must build systems that actually model the causal structure of the world, so that they are able to cope with a rapidly changing world and solve problems in more flexible ways, he said.

MIT-IBM Watson AI Lab, where Cox works, has been working on neurosymbolic systems that bring together deep learning with classic, symbolic AI techniques. In symbolic AI, human programmers explicitly specify the rules and details of the systems behavior instead of training it on data. Symbolic AI was dominant before the rise of deep learning and is better suited for environments where the rules are clearcut. On the other hand, it lacks the ability of deep learning systems to deal with unstructured data such as images and text documents.

The combination of symbolic AI and machine learning has helped create systems that can learn from the world, but also use logic and reasoning to solve problems, Cox said.

IBMs neurosymbolic AI is still in the research and experimentation stage. The company is testing it in several domains, including banking.

Teradatas Kureishy pointed to another problem that is plaguing the AI community: labeled data. Most machine learning systems are supervised, which means before they can perform their functions, they need to be trained on huge amounts of data annotated by humans. As conditions change, the machine learning models need new labeled data to adjust themselves to new situations.

Kureishy suggested that the use of active learning can, to a degree, help address the problem. In active learning models, human operators are constantly monitoring the performance of machine learning algorithms and provide them with new labeled data in areas where their performance starts to degrade. These active learning activities require both human-in-the-loop and alarms for human intervention to choose what data needs to be relabeled, based on quality constraints, Kureishy said.

But as automated systems continue to expand, human efforts fail to meet the growing demand for labeled data. The rise of data-hungry deep learning systems has given birth to a multibillion-dollar data-labeling industry, often powered by digital sweatshops with underpaid workers in poor countries. And the industry still struggles to create enough annotated data to keep machine learning models up to date. We will need deep learning systems that can learn from new data with little or no help from humans.

As supervised learning models are more common in the enterprise, they need to be data-efficient so that they can adapt much faster to changing behaviors, Kureishy said. If we keep relying on humans to provide labeled data, AI adaptation to novel situations will always be bounded by how fast humans can provide those labels.

Deep learning models that need little or no manually labeled data is an active area of AI research. In last years AAAI Conference, deep learning pioneer Yann LeCun discussed progress in self-supervised learning, a type of deep learning algorithm that, like a child, can explore the world by itself without being specifically instructed on every single detail.

I think self-supervised learning is the future. This is whats going to allow our AI systems to go to the next level, perhaps learn enough background knowledge about the world by observation, so that some sort of common sense may emerge, LeCun said in his speech at the conference.

But as is the norm in the AI industry, it takes yearsif not decadesbefore such efforts become commercially viable products. In the meantime, we need to acknowledge and embrace the power and limits of current AI.

These are not your static IT systems, Sharma says. Enterprise AI solutions are never done. They need constant re-training. They are living, breathing engines sitting in the infrastructure. It would be wrong to assume that you build an AI platform and walk away.

Ben Dickson is a software engineer, tech analyst, and the founder of TechTalks.

See the article here:

How the Coronavirus Pandemic Is Breaking Artificial Intelligence and How to Fix It - Gizmodo

R3 Stem Cell International Now Offering Four Joint Injections for Only $3950 in Mexico – Yahoo Finance

R3 Stem Cell International is now offering patients the opportunity to receive four stem cell joint injections for only $3950. With 50 million stem cells total, patients may choose which extremities they would like treated.

SCOTTSDALE, Ariz., July 29, 2020 /PRNewswire-PRWeb/ -- R3 Stem Cell International is now offering patients the opportunity to receive four stem cell joint injections for only $3950. With 50 million stem cells total, patients may choose which extremities they would like treated.

Several studies have shown just how well stem cell therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained from a lab with a long history of accreditation and pristine safety record. The lab abides by quality assurance standards that exceed those of the FDA.

Stem cell treatment for knees in Mexico at R3 works amazingly well. Patient satisfaction surveys at the center reveal that nine out of ten patients say they would have the procedure again and recommend it to friends and family.

According to R3 CEO David Greene, MD, MBA, "The biologics don't need preservative and viability exceeds 95%. The pureness and potency truly makes the difference in outcomes. Four joints for under $4000? What we put together for patients is incredible!"

The treatment process begins with a free phone consultation with one of R3's licensed, experienced stem cell doctors. Because the treatment includes 50 million stem cells, four joints may be included. The dedicated patient concierge representative assists with travel logistics. Travel from San Diego is included to the clinic, which is only 20 minutes from the San Diego airport.

Image guidance is used at the Center to ensure injection accuracy. In addition to arthritis treatment, R3 International offers stem cell treatment for autism, Lyme, COPD, kidney failure, neuropathy, diabetes, MS, ALS, stroke and much more.

Call (888) 988-0515 to learn more about therapies offered, and visit https://stemcelltreatmentclinic.com to read about the process.

SOURCE R3 Stem Cell International

More here:

R3 Stem Cell International Now Offering Four Joint Injections for Only $3950 in Mexico - Yahoo Finance

Industry News: Avacta and Daewoong Pharmaceutical expand partnership to include COVID-19 neutralising Affimer therapy – SelectScience

Collaboration to develop stem cell therapies for COVID-19 and future pandemic diseases

Avacta Group plc , the developer of Affimer biotherapeutics and reagents, has announced an expansion of its collaboration and license agreement with Daewoong Pharmaceutical Co. Ltd. and AffyXell Therapeutics, the joint venture established in South Korea by the two companies, to develop stem cell treatments incorporating Avactas neutralizing Affimer therapy for the treatment of seriously ill patients with COVID-19 and to also prepare to rapidly develop similar therapies for future global pandemics.

Respiratory diseases such as COVID-19 can cause serious damage to the lungs as a consequence of over-activation of the patient's immune system, resulting in cytokine release syndrome that can potentially lead to multiple organ failure and death. Stem cell therapies offer a very promising approach to repair the damage to lung tissues in these pulmonary diseases by controlling the immune balance.

AffyXell Therapeutics, the next-generation cell and gene therapy joint venture between Avacta and Daewoong Pharmaceutical, is developing a novel class of mesenchymal stem cell (MSC) treatments that are engineered to also produce Affimer therapies in the patient at the site of action.

The expansion of the agreement between Avacta, Daewoong Pharmaceutical and AffyXell announced today extends the scope of the partnership to include Affimer molecules that target viruses, such as coronaviruses, in order to develop therapies that repair the lung damage caused by COVID-19 whilst also producing neutralizing Affimer molecules to prevent the progression of the disease.

AffyXell will engineer mesenchymal stem cells to express SARS-COV-2 neutralizing Affimer molecules in order to develop treatments for seriously ill COVID-19 patients, and will also prepare for rapid development of next-generation stem cell therapies for future infectious respiratory disease outbreaks.

Dr. Alastair Smith, Chief Executive of Avacta Group commented: I am very pleased to have extended our collaboration and license agreement with Daewoong Pharmaceutical to include the SARS-COV-2 neutralizing Affimer molecules for the treatment of COVID-19 and to create the potential to respond very rapidly in future to global virus threats.

AffyXell will address the need over the coming years for advanced stem cell therapies to treat lung damage caused by cytokine release syndrome suffered by COVID-19 patients and, at the same time, help prevent disease progression in these patients through the action of a neutralizing Affimer therapy.

More broadly, one of the key areas of unmet clinical need that AffyXell can address with its next-generation mesenchymal stem cell therapies is acute pulmonary diseases such as COPD and acute respiratory distress syndrome. We, and our partners in South Korea, are very excited by the potential to develop life-improving treatments for patients with these serious respiratory diseases as well as COVID-19.

I look forward to further updating the market on progress in our ground-breaking programs with AffyXell in due course, and on progress with our COVID-19 diagnostics programs shortly.

Seng-ho Jeon, CEO of Daewoong Pharmaceutical and AffyXell Therapeutics, commented:It is very encouraging that AffyXell now has the opportunity to expand the application of its next-generation stem cell platform technology to target viruses. The SARS-COV-2 neutralizing Affimer to be developed in combination with AffyXells cell and gene technology is expected to be an innovative solution for COVID-19 patients suffering cytokine release syndrome.

Daewoong has been also conducting several research programs and clinical trial for COVID-19. As the COVID-19 crisis has caused great difficulties worldwide, we will continue to focus our efforts to develop a novel therapeutic agent for COVID-19.

Want more of the latest science news straight to your inbox?Become a SelectScience member for free today>>

Read the original here:

Industry News: Avacta and Daewoong Pharmaceutical expand partnership to include COVID-19 neutralising Affimer therapy - SelectScience

$30+ Billion Cell Expansion Market by Product, Cell Type, Application, End-user and Region – Forecast to 2025 – ResearchAndMarkets.com – Yahoo Finance

The "Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research), End-User, and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global cell expansion market is projected to reach USD 30.06 billion by 2025 from an estimated USD 14.91 billion in 2020, at a CAGR of 15.1%.

The report segments the cell expansion market based on region (Asia Pacific, Europe, North America, and RoW), product (consumables and instruments), cell type (human cells and animal cells), application (regenerative medicine and stem cell research, cancer and cell-based research and other applications), and end user (research institutes, biotechnology and biopharmaceutical companies, cell banks, and other end users). The report also provides a comprehensive review of market drivers, restraints, and opportunities in the cell expansion market.

Increasing incidence of chronic diseases and government investments for cell-based research are set to drive the cell expansion market

Growth in this market is largely driven by the increasing incidence of chronic diseases, government investments for cell-based research, growing focus on personalized medicine, increasing focus on R&D for cell-based therapies, and increasing GMP certifications for cell therapy production facilities. On the other hand, ethical concerns regarding research in cell biology are expected to limit market growth to a certain extent in the coming years.

By instruments type, the cell expansion supporting equipment accounted for the fasted growing product segment of the cell expansion market

The instruments segment includes cell expansion supporting equipment, bioreactors, and automated cell expansion systems. The cell expansion supporting equipment market includes flow cytometers, cell counters and hemocytometers, centrifuges, and other supporting equipment. They are used in cell culture processes for isolating, culturing, scaling-up, and extracting biological products. These instruments are essential in laboratories and institutes for conducting research and analyzing the cell structure and function for cell therapy research.

By cell type, the human cells segment accounted for the largest share of the cell expansion market

Based on cell type, the cell expansion market is segmented into human cells and animal cells. The human cells segment includes stem cells and differentiated cells. The stem cells segment is further classified into adult stem cells, ESCs, and iPSCs. The human cells segment accounted for the larger share of the cell expansion market majorly due to the increasing investments by public and private organizations for research on human cells, growing application areas of human stem cells, and the growing incidence of diseases such as cancer.

Asia Pacific: The fastest-growing region in the cell expansion market

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to the increasing focus of players on emerging Asian markets, increasing incidence of chronic and infectious diseases, rising geriatric population, and government initiatives for infrastructural improvements of healthcare facilities are driving the growth of the cell expansion market in this region.

North America: the largest share of the cell expansion market

North America accounted for the largest share of the cell expansion market. The large share of this segment can primarily be attributed to the rising incidence of cancer, increasing government funding, rising research activates on stem cell therapies, growing awareness regarding advanced treatment methods, growing geriatric population, and the strong presence of industry players in the region.

Company Profiles

Established Companies

Start-up Companies

For more information about this report visit https://www.researchandmarkets.com/r/y35ufs

View source version on businesswire.com: https://www.businesswire.com/news/home/20200729005450/en/

Contacts

ResearchAndMarkets.comLaura Wood, Senior Press Managerpress@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900

More:

$30+ Billion Cell Expansion Market by Product, Cell Type, Application, End-user and Region - Forecast to 2025 - ResearchAndMarkets.com - Yahoo Finance

Global Stem Cell Therapy Market 2020 Analysis by Geographical Regions, Type and Application Till 2027 – Market Research Posts

This latest report studies Stem Cell Therapy Market globally, particularly in North America, Europe(Germany, UK, France, Italy, Spain, Russia, Poland), China, Japan, Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam) the Middle East and Africa(Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria), India, South America(Brazil, Mexico, Colombia), with revenue, import, and export, production, consumption in these regions, from 2015 to 2019, and forecast 2020 to 2027. Global Stem Cell Therapy market 2020 research report is replete with precise analysis from radical studies, specifically on queries that approach market size, trends, share, forecast, outlook, production, and futuristic developments trends and present and future market status.

Then, the report focuses on world major leading industry players with information like company profiles, product picture and specifications, Sales Revenue, Price, gross margin, market share, and contact info. In addition, the Stem Cell Therapy industry development trends and marketing channels are analyzed.

Request For Free Sample Report:

https://www.reportspedia.com/report/business-services/2015-2027-global-stem-cell-therapy-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/57925#request_sample

Analysis of Stem Cell Therapy market Key manufacturers (Sales Revenue, Price, gross margin, main products, etc.):

Celgene CorporationOsiris Therapeutics, Inc.Pharmicell Co., LtdMEDIPOST Co., Ltd.Promethera BiosciencesFibrocell Science, Inc.Holostem Terapie Avanzate S.r.l.Cytori TherapeuticsNuvasive, Inc.RTI Surgical, Inc.Anterogen Co., Ltd.RTI Surgical, Inc

Analysis of Stem Cell Therapy Market By Product Types(Market Size & Forecast):

Adult Stem CellsHuman EmbryonicInduced Pluripotent Stem CellsVery Small Embryonic Like Stem Cells

Analysis of Stem Cell Therapy Market By Applications(Market Size & Forecast):

Regenerative MedicineDrug Discovery and Development

In additional, the manufacturers dominant within the global Stem Cell Therapy Market are highlighted inside the competitive landscape section of the report. The competitive state of affairs and trends current within the market have additionally been encapsulated underneath this section of the study. moreover, the mergers and acquisitions that passed off within the market in the past few years and their impact on the markets development has in addition been bestowed underneath this a part of the report.

Ask For Discount: https://www.reportspedia.com/discount_inquiry/discount/57925

Furthermore, it describes the in-depth analysis of key Stem Cell Therapy market segments and sub-segments, particularly includes evolving Stem Cell Therapy industry trends and dynamics, challenges, and competitive insights, technological breakthroughs for Stem Cell Therapy market development mapping with different opportunities. The report also analyzes the Stem Cell Therapy industry potential for every geographical region consequently.

With the list of tables and figures, the report provides key statistics on the condition of the business and could be a valuable supply of steerage and direction for firms and people curious about the market.

Any Query Or Specific Requirement? Ask to our Research expert @

https://www.reportspedia.com/report/business-services/2015-2027-global-stem-cell-therapy-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/57925#inquiry_before_buying

TOC of Stem Cell Therapy Market Contains Following Points:

Table of Content & Table Of Figures

https://www.reportspedia.com/report/business-services/2015-2027-global-stem-cell-therapy-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/57925#table_of_contents

Here is the original post:

Global Stem Cell Therapy Market 2020 Analysis by Geographical Regions, Type and Application Till 2027 - Market Research Posts

Arson at The Way Christian Center and The Shortage of Stem Cell Donors of Color – KPFA – 94.1FM

Davey D brings us audio from todays press conference held at The Way Christian Center in Berkeley Ca. Less than 12 hours after The Way Christian Center placed a Black Lives Matter banner, someone set fire to several trash cans positioned at the back of the church. The act of arson, damaged a portion of the building (see photos below) and has created fear and anger in the community.

Later we speak with Jess Tom and Carol Gillespie about treatment for blood-related cancers, the shortage of stem cell donors of color and the need to improve the registries. Seventy percent of patients wont have a match in their families and must find an unrelated donor. Patients are more likely to match donors who share the same ethnic background, but the lack of diversity on the Be The Match national registry makes it difficult for patients to find one. The Asian American Donor Program (AADP, https://www.aadp.org), a nonprofit organization in Alameda, is urging individuals to register as a potential stem cell donor. Join the registry by texting AADP to 61474

Guests:

Pastor Michael McBride (known as Pastor Mike) The fire was an act of terror, said Pastor Michael McBride, who leads the 48-year-old Way Christian Church.

Pastor Michael McBride is a native of San Francisco, CA. and has been active in ministry for almost 20 years. In June 2005, Pastor McBridelaunched a new ministry, The Way Christian Center in West Berkeley, where he presently serves as thePastor.

Carol Gillespie, Executive Director, Asian American Donor Program

Carol Gillespie is one of the original members of the Board of Directors for the Asian American Donor Program (AADP) when it was founded in 1989. She volunteered for AADP for3 years before accepting the position as Project Administrator in 1992. In 2002, Gillespie was selected as AADPs Executive Director and is currently serving in that position.

Jess Tom, Chef, Author, and TV Guest

Jess Tom is the sister of Andrew, who at 29 years old was living his dream and engaged to the love of his life. In May 2020 Andrew went to the doctor for swollen lymph nodes. A couple of days later, he was diagnosed withmixed phenotype acute leukemia (MPAL), a rare and aggressive form of leukemia. MPAL accounts for only 2-5% of all leukemias. The only way he can beat the illness is with a stem cell transplant.

In order to have a stem cell transplant, first a stem cell match for Andrew must be found. No one in Andrews family is a match. As being a match is genetically based, Andrews stem cell match will most likely be someone who is Chinese.Chinese donors only make up 0.7% of the national donor registry, leaving him with only a 43% chance of finding a perfect match.

Jess Tom has been working with the Asian American Donor Program, a nonprofit organization, to encourage Chinese Americans to register as potential stem cell donors. Sheis a chef and winner of season 14 ofFood Network Star. Jess Tom is a writer and food blogger living in Brooklyn.

She is the author ofFOOD WHORE: A Novel of Dining & Deceitpublished by William Morrow/HarperCollins. The paperback edition was released in 2015.FOOD WHORE, Jess first novel, merges her love of food and fiction.

You can find Jess on stage, online and on television, appearing on the Food Network, Good Morning America, the Today Show, and more.She has worked on initiatives with food trucks, restaurants, hospitality startups, and citywide culinary programs.

Excerpt from:

Arson at The Way Christian Center and The Shortage of Stem Cell Donors of Color - KPFA - 94.1FM

Canine Stem Cell Therapy Market Segment Analysis by Leading Players, Drivers, Regional, Competitive Landscape & Forecast To 2019 2029 – Owned

A synopsis of the global canine stem cell therapy market with reference to the global healthcare pharmaceutical industry

Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.

A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry. Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, blockchain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets.

Parent Indicators Healthcare Current expenditure on health, % of gross domestic product Current expenditure on health, per capita, US$ purchasing power parities (current prices, current PPPs) Annual growth rate of current expenditure on health, per capita, in real terms Out-of-pocket expenditure, % of current expenditure on health Out-of-pocket expenditure, per capita, US$ purchasing power parity (current prices, current PPPs) Physicians, Density per 1000 population (head counts) Nurses, Density per 1000 population (head counts) Total hospital beds, per 1000 population Curative (acute) care beds, per 1000 population Medical technology, Magnetic Resonance Imaging units, total, per million population Medical technology, Computed Tomography scanners, total, per million population

Research Methodology

This Press Release will help you to understand the Volume, growth with Impacting Trends. Click HERE To get SAMPLE PDF (Including Full TOC, Table & Figures) athttps://www.xploremr.com/connectus/sample/2360

XploreMR utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, to obtain precise market estimations and insights on Molecule and Drug Classes, API Formulations and preferred modes of administration. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.

Secondary research is used at the initial phase to identify the age specific disease epidemiology, diagnosis rate and treatment pattern, as per disease indications. Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.

Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, nursing managers, clinical specialists who provide valuable insights on trends and clinical application of the drugs, key treatment patterns, adoption rate, and compliance rate.

Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.

On the other hand, we also analyse various companies annual reports, investor presentations, SEC filings, 10k reports and press release operating in this market segment to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at Tier level based on their revenues, product portfolio and presence.

Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as per capita healthcare expenditure, disposable income, industry based demand driving factors impacting the market and its forecast trends apart from disease related factors.

Request Report Methodology at https://www.xploremr.com/connectus/request-methodology/2360

Standard Report Structure Executive Summary Market Definition Macro-economic analysis Parent Market Analysis Market Overview Forecast Factors Segmental Analysis and Forecast Regional Analysis Competition Analysis

Target Audience Production Companies Suppliers Channel Partners Marketing Authorities Subject Matter Experts Research Institutions Financial Institutions Market Consultants Government Authorities

Market Taxonomy

The global canine stem cell therapy market has been segmented into:

Product Type: Allogeneic Stem Cells Autologous Stem cells

Application: Arthritis Dysplasia Tendonitis Lameness Others

End User: Veterinary Hospitals Veterinary Clinics Veterinary Research Institutes

Region: North America Latin America Europe Asia Pacific Japan Middle East & Africa

Buy Full Report at https://www.xploremr.com/cart/2360/SL

About Us

XploreMR, a leading market research firm, headquartered in San Jose, USA, XploreMR has, in a short span of time, served the market research needs of some of the biggest Fortune 500 companies. XploreMR also has highly personalized market research offerings for SMEs, and we pride ourselves on being uniquely positioned to have worked with colossal multinational firms and small, boutique firms. Our experience of working with such a diverse set from all over the world has given us invaluable perspectives on objectives, outlooks, goals, and eventually, the collective, symbiotic growth that stakeholders across the value chain aspire for. We keep these perspectives and aspirations in mind every time we work on a project, and this motivates us to exceed client expectations on a consistent basis.

Contact us:XploreMR111 North Market Street, Suite 300,San Jose, CA 95113, United StatesPh.No: +16692840108E-mail id- [emailprotected]Web- https://www.xploremr.com

Follow this link:

Canine Stem Cell Therapy Market Segment Analysis by Leading Players, Drivers, Regional, Competitive Landscape & Forecast To 2019 2029 - Owned

Avacta and Daewoong Pharmaceutical expand partnership to include COVID-19 neutralising Affimer therapy – Cambridge Network

Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and reagents, is pleased to announce an expansion of its collaboration and licence agreement with Daewoong Pharmaceutical Co. Ltd. (KSX: 069620) and AffyXell Therapeutics, the joint venture established in South Korea by the two companies, to develop stem cell treatments incorporating Avactas neutralising Affimer therapy for the treatment of seriously ill patients with COVID-19 and to also prepare to rapidly develop similar therapies for future global pandemics.

Respiratory diseases such as COVID-19 can cause serious damage to the lungs as a consequence of over-activation of the patient's immune system, resulting in cytokine release syndrome that can potentially lead to multiple organ failure and death. Stem cell therapies offer a very promising approach to repair the damage to lung tissues in these pulmonary diseases by controlling the immune balance.

AffyXell Therapeutics, the next-generation cell and gene therapy joint venture between Avacta and Daewoong Pharmaceutical, is developing a novel class of mesenchymal stem cell (MSC) treatments that are engineered to also produce Affimer therapies in the patient at the site of action.

The expansion of the agreement between Avacta, Daewoong Pharmaceutical and AffyXell announced today extends the scope of the partnership to include Affimer molecules that target viruses, such as coronaviruses, in order to develop therapies that repair the lung damage caused by COVID-19 whilst also producing neutralising Affimer molecules to prevent the progression of the disease.

AffyXell will engineer mesenchymal stem cells to express SARS-COV-2 neutralising Affimer molecules in order to develop treatments for seriously ill COVID-19 patients, and will also prepare for rapid development of next-generation stem cell therapies for future infectious respiratory disease outbreaks.

Dr Alastair Smith, Chief Executive of Avacta Group commented: I am very pleased to have extended our collaboration and licence agreement with Daewoong Pharmaceutical to include the SARS-COV-2 neutralising Affimer molecules for the treatment of COVID-19 and to create the potential to respond very rapidly in future to global virus threats.

"AffyXell will address the need over the coming years for advanced stem cell therapies to treat lung damage caused by cytokine release syndrome suffered by COVID-19 patients and, at the same time, help prevent disease progression in these patients through the action of a neutralising Affimer therapy.

"More broadly, one of the key areas of unmet clinical need that AffyXell can address with its next-generation mesenchymal stem cell therapies is acute pulmonary diseases such as COPD and acute respiratory distress syndrome. We, and our partners in South Korea, are very excited by the potential to develop life improving treatments for patients with these serious respiratory diseases as well as COVID-19.

"I look forward to further updating the market on progress in our ground-breaking programmes with AffyXell in due course, and on progress with our COVID-19 diagnostics programmes shortly.

Seng-ho Jeon, CEO of Daewoong Pharmaceutical and AffyXell Therapeutics, commented: It is very encouraging that AffyXell now has the opportunity to expand the application of its next-generation stem cell platform technology to target viruses. The SARS-COV-2 neutralising Affimer to be developed in combination with AffyXells cell and gene technology is expected to be an innovative solution for COVID-19 patients suffering cytokine release syndrome.

"Daewoong has been also conducting several research programs and clinical trial for COVID-19. As the COVID-19 crisis has caused great difficulties worldwide, we will continue to focus our efforts to develop a novel therapeutic agent for COVID-19.

This announcement contains information which, prior to its disclosure, was considered inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 (MAR).

See the rest here:

Avacta and Daewoong Pharmaceutical expand partnership to include COVID-19 neutralising Affimer therapy - Cambridge Network

Impact of COVID-19 on Cell Freezing Media for Cell Therapy Market Overview with Detailed Analysis, Competitive Landscape & Forecast To 2026 -…

Innovative Report on Cell Freezing Media for Cell Therapy Market with Competitive Analysis, New Business Developments, and Top Companies

A perfect mix of quantitative & qualitative Cell Freezing Media for Cell Therapy Market Market information highlighting developments, industry challenges that competitors are facing along with gaps and opportunities available and would trend in Cell Freezing Media for Cell Therapy Market. The study bridges the historical data from 2014 to 2019 and estimated until 2026.

Prominent players profiled in the study: BioLife Solutions, Akron Biotechnology, GE Healthcare, Thermo Fisher Scientific, Biological Industries, Merck, WAK-Chemie Medical, Zenoaq

Sample Report with Latest Industry Trends @https://www.acquiremarketresearch.com/sample-request/379423/

Covid-19 pandemic affects most industries in the globe. Here at acquire market research we offer you comprehensive data of related industry which will help and support your business in all possible ways.

This Report Provides an overview of the Cell Freezing Media for Cell Therapy market, containing global revenue, global production, sales, and CAGR. Also describe Cell Freezing Media for Cell Therapy product scope, market overview, market opportunities, market driving force, and market risks. The forecast and analysis of the Cell Freezing Media for Cell Therapy market by type, application, and region are also presented. The next part of the report provides a full-scale analysis of Cell Freezing Media for Cell Therapy competitive situation, sales, revenue and global market share of major players in the Cell Freezing Media for Cell Therapy industry. The basic information, as well as the profiles, applications, and specifications of products market performance along with Business Overview, are offered.

With FBS, Without FBS: With FBS, Without FBS

Application: Human Embryonic Stem Cells, CAR-T Cell Therapy, Neural Stem Cell Therapy, Mesenchymal Stem Cell Therapy, Hematopoietic Stem Cell Transplantation, Other

Geographical Regions: North America, Europe, Central & South America, Asia-Pacific, and the Middle East & Africa, etc.

Get Reasonable Discount on this Premium Report @https://www.acquiremarketresearch.com/discount-request/379423/

Scope of the Cell Freezing Media for Cell Therapy Report:

Worldwide Cell Freezing Media for Cell Therapy Market 2020, Market Size Value CAGR (XX %) and revenue (USD Million) for the historical years (2016 to 2019) and forecast years (2020 to 2026), with SWOT analysis, Industry Analysis, Demand, Sales, Market Drivers, Restraints, Opportunities and Forecast to 2026 cover in this research report.

As a part of our Corporate Social Responsibility, we would like to announce that we would be contributing 15 % of our profits to USA, UK, Italy, Spain and India relief fund.

This report covers the current scenario and growth prospects of the Cell Freezing Media for Cell Therapy Market for the period 2020-2026. The study is a professional and in-depth study with around tables and figures which provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the domain.

Finally, all aspects of the Global Cell Freezing Media for Cell Therapy Market are quantitatively as well qualitatively assessed to study the Global as well as regional market comparatively. This market study presents critical information and factual data about the market providing an overall statistical study of this market on the basis of market drivers, limitations and future prospects.

Browse Full [emailprotected] https://www.acquiremarketresearch.com/industry-reports/cell-freezing-media-for-cell-therapy-market/379423/

About us:

Acquire Market Research is a market research-based company empowering companies with data-driven insights. We provide Market Research Reports with accurate and well-informed data, Real-Time with Real Application. A good research methodology proves to be powerful and simplified information that applied right from day-to-day lives to complex decisions helps us navigate through with vision, purpose and well-armed strategies. At Acquire Market Research, we constantly strive for innovation in the techniques and the quality of analysis that goes into our reports.

Contact Us:

Sally Mach555 Madison Avenue,5th Floor, Manhattan,New York, 10022 USAPhone No.: +1 (800) 663-5579Email ID: [emailprotected]

Read this article:

Impact of COVID-19 on Cell Freezing Media for Cell Therapy Market Overview with Detailed Analysis, Competitive Landscape & Forecast To 2026 -...

Stem Cell Therapy Market Analysis and Forecast 2019 | By Top Players Magellan, Medipost Co., Ltd, Osiris Therapeutics, Inc., Kolon TissueGene, Inc.,…

A new business intelligence report released by CMI with title GlobalStem Cell Therapy MarketResearch Report 2019-2027 is designed covering micro level of analysis by manufacturers and key business segments. The Global Stem Cell Therapy Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and it comprises both qualitative and quantitative detailing. Some of the key players profiled in the study are Magellan, Medipost Co., Ltd, Osiris Therapeutics, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Anterogen Co. Ltd., Pharmicell Co., Inc., and Stemedica Cell Technologies, Inc.

Whats keeping Magellan, Medipost Co., Ltd, Osiris Therapeutics, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Anterogen Co. Ltd., Pharmicell Co., Inc., and Stemedica Cell Technologies, Inc. Ahead in the Market? Benchmark yourself with the strategic moves and findings recently released by CMI

Leading players of Stem Cell Therapy Market:

Magellan, Medipost Co., Ltd, Osiris Therapeutics, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Anterogen Co. Ltd., Pharmicell Co., Inc., and Stemedica Cell Technologies, Inc.

Stem Cell Therapy Geographical Segmentation Includes:

North America (U.S., Canada, Mexico)

Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)

Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)

Latin America (Brazil, Rest of L.A.)

Middle East and Africa (Turkey, GCC)

The research report includes an exploration of the competitive landscape present in the Stem Cell Therapy Market. It includes an import of the current and future trends that players can invest in. Likewise, it also includes an estimation of the business outlooks of the players and explains the nature of the competition.

Stem Cell Therapy Market Segmentation

By Cell Source:Adult Stem CellsInduced Pluripotent Stem CellsEmbryonic Stem CellsOthersGlobal Stem Cell Therapy Market, By Application:Musculoskeletal DisordersWounds and InjuriesCancerAutoimmune disordersOthers

The plus point of this research study is that it includes the impact of COVID-19 to the Stem Cell Therapy market. The data summarized within this research study includes forecast from 2020 to 2027. COVID-19 has significantly impacted each and every market on the global platform. If you have any specific requirement then Please get in touch with us. Our Expert team will provide as per report customized to your requirement.

Important Features of the report:

Reasons for buying this report:

It offers the regional analysis of the Stem Cell Therapy Market along with the business profiles of several stakeholders.

Some Major TOC Points:

Chapter 1. Stem Cell Therapy Market Report Overview

Chapter 2. Stem Cell Therapy industry Growing Trends

Chapter 3. Market Share by Key vendors

Chapter 4. Stem Cell Therapy Market Breakdown Data by Type and Application

Chapter 5. Stem Cell Therapy Market by End Users/Application

Chapter 6. COVID-19 Outbreak: Stem Cell Therapy Industry Impact

Chapter 7. Opportunity Analysis in Covid-19 Crisis

Chapter 9. Market Driving Factors

And Many More

Apply Promo Code CMIFIRST1000 And Get Instant Discount OfUSD 1000

Download PDF Brochure Of this Report @https://www.coherentmarketinsights.com/insight/request-pdf/2848

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, LATAM, West Europe, MENA Countries, Southeast Asia or Asia Pacific.

About us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contacts US

Mr. ShahUS +1-206-701-6702/UK +44-020 8133 4027Email: [emailprotected]

The rest is here:

Stem Cell Therapy Market Analysis and Forecast 2019 | By Top Players Magellan, Medipost Co., Ltd, Osiris Therapeutics, Inc., Kolon TissueGene, Inc.,...